The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Identification and management of pathogenic mutations in BRCA1, BRCA2, and PALB2 in a tumor-only genomic testing program.
 
Brittany L. Bychkovsky
No Relationships to Disclose
 
Tianyu Li
No Relationships to Disclose
 
Jilliane Sotelo
Employment - Thermo Fisher Scientific
Consulting or Advisory Role - Invitae
Research Funding - National Society of Genetic Counselors
 
Nabihah Tayob
No Relationships to Disclose
 
Joanna Mercado
Employment - Genome Medical
 
Israel Gomy
Research Funding - CAPES Foundation
 
Anu B. Chittenden
Employment - Immunogen (I)
Consulting or Advisory Role - Boston Pharmaceuticals (I)
 
Sarah R. Kane
No Relationships to Disclose
 
Samantha Stokes
No Relationships to Disclose
 
Melissa E Hughes
No Relationships to Disclose
 
Ji Seok Kim
Employment - Dewpoint Therapeutics
 
Mark M. Awad
Consulting or Advisory Role - Abbvie; Achilles Therapeutics; Archer; ARIAD; AstraZeneca; AstraZeneca/MedImmune; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; EMD Serono; Foundation Medicine; Genentech; Gritstone Bio; Hengrui Therapeutics; Maverick Therapeutics; Merck; Mirati Therapeutics; Nektar; Neon Therapeutics; NextCure; Novartis; Panasonic; Pfizer; Syndax
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst)
 
Panagiotis A. Konstantinopoulos
Consulting or Advisory Role - Alkermes; AstraZeneca; Bayer; Merck; Pfizer/EMD Serono; Repare Therapeutics; Tesaro; Vertex
Research Funding - AstraZeneca (Inst); Bayer (Inst); Lilly (Inst); Merck (Inst); Merck Serono (Inst); Pfizer (Inst); tesaro (Inst)
 
Brian M. Wolpin
Honoraria - Celgene; G1 Therapeutics
Consulting or Advisory Role - BioLineRx; Celgene; G1 Therapeutics; Genentech; GRAIL; GRAIL
Research Funding - Celgene; Lilly
 
Mary-Ellen Taplin
Honoraria - Abbvie; Amgen; Arcus Biosciences; Astellas Pharma; AstraZeneca; Bayer; Celgene; Clovis Oncology; Constellation Pharmaceuticals; GlaxoSmithKline; Guidepoint Global; Incyte; Janssen-Ortho; Merck; Myovant Sciences; Pfizer; Pfizer; Progenics; Research to Practice; Roivant; UpToDate
Consulting or Advisory Role - Arcus Ventures (I); AstraZeneca; Bayer; Best Doctors, Inc; Clovis Oncology; Guidepoint Global; Incyte; Janssen-Ortho; Myovant Sciences; Pfizer; Research to Practice; UpToDate
Research Funding - Bayer (Inst); Janssen-Ortho (Inst); Medivation (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Clovis Oncology; Incyte; Janssen Oncology; Medivation; Pfizer; Tokai Pharmaceuticals
 
Bruce E. Johnson
Consulting or Advisory Role - Checkpoint Therapeutics; Chugai Pharma; Daiichi Sankyo; Foundation Medicine; G1 Therapeutics; Hengrui Therapeutics; Jazz Pharmaceuticals; Lilly; Novartis
Research Funding - Novartis; Novartis (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Dana-Farber Cancer Institute
 
Neal Ian Lindeman
No Relationships to Disclose
 
Laura E MacConaill
No Relationships to Disclose
 
Judy Ellen Garber
Consulting or Advisory Role - Aleta BioTherapeutics (I); GTx (I); H3 Biomedicine (I); Helix BioPharma; Konica Minolta; Kronos Bio (I); Novartis (I)
Research Funding - Ambry Genetics; InVitae; Myriad Genetics; Novartis (I)
Other Relationship - AACR; Adrienne Helis Malvin Medical Research Foundation (I); Breast Cancer Research Foundation; Diana Helis Henry Medical Foundation (I); Facing our Risk of Cancer Empowered; James P. Wilmot Foundation (I); Susan G. Komen for the Cure (I)
 
Nancy U. Lin
Consulting or Advisory Role - AstraZeneca; California Institute for Regenerative Medicine (CIRM); Daiichi Sankyo; Denali Therapeutics; Prelude Therapeutics; Prelude Therapeutics; Puma Biotechnology; Seagen
Research Funding - Genentech; Merck; Pfizer; Seagen
Patents, Royalties, Other Intellectual Property - Royalties for chapter in Up-to-Date regarding management of breast cancer brain metastases; Royalties, Jones & Bartlett